Cargando...
Evaluating Sorafenib in Veterans With Advanced Hepatocellular Carcinoma
Sorafenib remains a viable therapeutic option for patients with advanced hepatocellular carcinoma but may present some risks for a veteran population.
Guardado en:
| Publicado en: | Fed Pract |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Frontline Medical Communications Inc.
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6364810/ https://ncbi.nlm.nih.gov/pubmed/30766031 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|